Monthly Archives: April 2016
Written on April 27, 2016 at 3:10 pm, by Amanda Maestri
I’ve shelved this post for almost a year now because though I’ve been in venture for five years across both Wildcat Venture Partners and Mohr Davidow Ventures, it’s not lost on me that I’m still too early in my career to be “rocking the boat”. But thanks to Gurley’s recent article, the cat is out Continue Reading »
Written on April 25, 2016 at 6:53 pm, by Amanda Maestri
An awful lot of tech stuff is going down these days, and it is creating some serious confusion. Whiskey, Tango, Foxtrot is rapidly becoming the call sign for our current era. We may not yet feel we are in jeopardy, but we certainly do not feel in control. What in the world is going on?
Written on April 19, 2016 at 3:39 am, by Amanda Maestri
The Girls in Tech Catalyst Conference is a three-day event showcasing women at the forefront of the technology and start-up spaces, with inspiring keynotes from female leaders, as well as workshops, panel discussions, and networking events. The conference offers attendees exciting discussion and sage advice on innovation and technology, and will provide them with a Continue Reading »
Written on April 19, 2016 at 3:28 am, by Amanda Maestri
Katherine Barr is one of more than three dozen leading executives who will be speaking at the Catalyst Conference. Read her interview with Girls in Tech <here>.
Written on April 12, 2016 at 12:49 am, by Amanda Maestri
The Viseo Talent Summit will bring together the tech industry’s best and brightest head of talent, recruitment, PE and VC investors and CxOs at the heart of today’s emerging enterprises. Join Elizabeth Patterson and panelists as they discuss the current challenges and solutions for attracting and keeping top talent in the competitive environment. A sampling Continue Reading »
Written on April 11, 2016 at 6:54 pm, by Amanda Maestri
As early stage venture investors who only invest in a select number of companies annually, we unfortunately have to pass on many great entrepreneurs and compelling visions. So when we do make an investment — Clover Health’s Series B, in this case — we are inevitably asked, “Why them? What’s special about that company?” I hope this post sheds Continue Reading »